{"id":"https://openalex.org/W7214896512","doi":"https://doi.org/10.3389/fimmu.2026.1998525","title":"Editorial: Implications of senescence in cancer immunology","display_name":"Editorial: Implications of senescence in cancer immunology","publication_year":2026,"publication_date":"2026-09-30","ids":{"openalex":"https://openalex.org/W7214896512","doi":"https://doi.org/10.3389/fimmu.2026.1998525","pmid":"https://pubmed.ncbi.nlm.nih.gov/42876907","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13661957"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1998525","doi":"https://doi.org/10.3389/fimmu.2026.1998525","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1998525","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1998525/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1998525/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074159017","display_name":"Alessandra Zingoni","orcid":"https://orcid.org/0000-0003-0906-1566","observed_orcids":["https://orcid.org/0000-0003-0906-1566"]},"institutions":[{"id":"https://openalex.org/I4210153523","display_name":"Istituto Pasteur","ror":"https://ror.org/051v7w268","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210153523"]},{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alessandra Zingoni","raw_affiliation_strings":["Department of Molecular Medicine, Laboratory Affiliated to Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Laboratory Affiliated to Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome","institution_ids":["https://openalex.org/I4210153523","https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038580329","display_name":"Gordon Cook","orcid":"https://orcid.org/0000-0003-1717-0412","observed_orcids":["https://orcid.org/0000-0003-1717-0412"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Gordon Cook","raw_affiliation_strings":["Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074355427","display_name":"Laura Senovilla","orcid":"https://orcid.org/0000-0001-6887-2436","observed_orcids":["https://orcid.org/0000-0001-6887-2436"]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]},{"id":"https://openalex.org/I134820265","display_name":"Consejo Superior de Investigaciones Cient\u00edficas","ror":"https://ror.org/02gfc7t72","country_code":"ES","type":"government","lineage":["https://openalex.org/I134820265"]},{"id":"https://openalex.org/I4210141160","display_name":"Instituto de Biomedicina y Gen\u00e9tica Molecular de Valladolid","ror":"https://ror.org/03kjyy960","country_code":"ES","type":"facility","lineage":["https://openalex.org/I108103353","https://openalex.org/I134820265","https://openalex.org/I4210141160"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Laura Senovilla","raw_affiliation_strings":["Institute of Biomedicine and Molecular Genetics (IBGM), Higher Council for Scientific Research (CSIC) - University of Valladolid (UVA)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Biomedicine and Molecular Genetics (IBGM), Higher Council for Scientific Research (CSIC) - University of Valladolid (UVA)","institution_ids":["https://openalex.org/I108103353","https://openalex.org/I134820265","https://openalex.org/I4210141160"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5038580329","https://openalex.org/A5074159017","https://openalex.org/A5074355427"],"corresponding_institution_ids":["https://openalex.org/I108103353","https://openalex.org/I130828816","https://openalex.org/I134820265","https://openalex.org/I4210141160","https://openalex.org/I4210153523","https://openalex.org/I861853513"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1998525","last_page":"1998525"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10676","display_name":"Genetics, Aging, and Longevity in Model Organisms","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1302","display_name":"Aging"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cellular-senescence","display_name":"cellular senescence","score":0.984000027179718},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.8769999742507935},{"id":"https://openalex.org/keywords/senescence-associated-secretory-phenotype","display_name":"senescence-associated secretory phenotype","score":0.8949999809265137},{"id":"https://openalex.org/keywords/immunosenescence","display_name":"immunosenescence","score":0.7649999856948853},{"id":"https://openalex.org/keywords/inflammaging","display_name":"inflammaging","score":0.9480000138282776},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9610000252723694},{"id":"https://openalex.org/keywords/oncolytic-virotherapy","display_name":"oncolytic virotherapy","score":0.9430000185966492},{"id":"https://openalex.org/keywords/therapy-induced-senescence","display_name":"therapy-induced senescence","score":0.921999990940094},{"id":"https://openalex.org/keywords/car-t","display_name":"CAR-T","score":0.5870000123977661},{"id":"https://openalex.org/keywords/bh3-profiling","display_name":"BH3 profiling","score":0.9110000133514404},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.5659999847412109},{"id":"https://openalex.org/keywords/aging","display_name":"aging","score":0.35100001096725464},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C522857546","wikidata":"https://www.wikidata.org/wiki/Q2070979","display_name":"Senescence","level":2,"score":0.8086000084877014},{"id":"https://openalex.org/C2779056147","wikidata":"https://www.wikidata.org/wiki/Q1660191","display_name":"Immunosenescence","level":3,"score":0.7635999917984009},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7620000243186951},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.555899977684021},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5389000177383423},{"id":"https://openalex.org/C2779523775","wikidata":"https://www.wikidata.org/wiki/Q9075999","display_name":"Cellular senescence","level":4,"score":0.4336000084877014},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4097000062465668},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.40470001101493835},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.3578999936580658},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3555999994277954},{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.3269999921321869},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3116999864578247},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.30869999527931213},{"id":"https://openalex.org/C2910239545","wikidata":"https://www.wikidata.org/wiki/Q3843811","display_name":"Immune Dysfunction","level":3,"score":0.2955000102519989},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.2870999872684479},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28619998693466187},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2849000096321106},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.27570000290870667},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2581999897956848},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2574999928474426},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.25609999895095825},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.25290000438690186}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fimmu.2026.1998525","doi":"https://doi.org/10.3389/fimmu.2026.1998525","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1998525","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1998525/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13661957","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13661957/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13661957/pdf/fimmu-17-1998525.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42876907","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42876907","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Editorial"},{"id":"pmh:oai:doaj.org/article:4a33795e561047c588050cf683e6baab","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/4a33795e561047c588050cf683e6baab","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"},{"id":"pmh:oai:iris.uniroma1.it:11573/1776262","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11573/1776262","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1998525","doi":"https://doi.org/10.3389/fimmu.2026.1998525","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1998525","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1998525/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214896512.pdf","grobid_xml":"https://content.openalex.org/works/W7214896512.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W3146830857","https://openalex.org/W3206142581","https://openalex.org/W4395050247","https://openalex.org/W4412884005"],"related_works":["https://openalex.org/W7161947396","https://openalex.org/W7134057863","https://openalex.org/W3035848897","https://openalex.org/W7147463754","https://openalex.org/W4410384357","https://openalex.org/W3100093629","https://openalex.org/W4411237546","https://openalex.org/W7134934773","https://openalex.org/W4413428153","https://openalex.org/W4405859959"],"abstract_inverted_index":{"As":[0],"emphasipzed":[1],"by":[2,25,32,308,404,489,533],"Xiao-Dan":[3],"Qian":[4],"et":[5,129,177,312,407,504,536,590],"al,":[6],"the":[7,105,123,132,169,187,206,326,338,349,422,461,464,490,516,527,577,593,600,618,626,647,673,705,710,749,771,791],"dual":[8],"nature":[9],"of":[10,28,125,163,171,190,198,217,233,241,325,328,340,352,377,449,466,474,482,530,579,599,621,632,672,712,734],"cellular":[11,88,378,766],"senescence":[12,77,119,136,235,278,291,296,345,541,580,623,659,685,736],"represents":[13],"a":[14,60,101,160,194,252,319,364,412,443,447,471,507,522,655,661,669],"central":[15],"challenge":[16],"for":[17,228,268,289,366,374,476,805],"cancer":[18,226,396,807],"immunology.":[19,808],"Senescence":[20],"can":[21,58,157,250,264,682,716],"restrain":[22],"tumor":[23,44,256,269,426,545,583,602,622,642,674],"growth":[24,584],"preventing":[26],"proliferation":[27],"damaged":[29],"cells":[30,45,149,173,330,354,397,427,451,468,795],"and":[31,39,53,63,90,137,147,155,201,213,220,224,247,279,322,333,373,417,432,492,515,549,559,574,585,612,624,644,739,744,768,787,796],"generating":[33],"signals":[34],"that":[35,49,263,348,393,463,605,629,789],"facilitate":[36],"immune":[37,54,68,73,95,188,218,400,418,517,547,707,742,772,797],"recognition":[38],"clearance.":[40,96],"However,":[41,295],"persistent":[42],"senescent":[43,148,164,172,253,282,353,395,425,444,467,601,633,794],"may":[46,70,82,150,355,428,469,568,608,752,799],"acquire":[47],"properties":[48],"favor":[50],"their":[51,435],"survival":[52],"escape.":[55],"The":[56,271,305,402,774],"SASP":[57],"establish":[59],"chronic":[61],"inflammatory":[62],"immunosuppressive":[64],"microenvironment,":[65,603],"while":[66],"senescence-associated":[67,483,606,717],"checkpoints":[69],"further":[71,487],"compromise":[72],"surveillance.":[74],"Thus,":[75],"whether":[76],"is":[78,120,299,387,486],"beneficial":[79],"or":[80,758],"detrimental":[81],"depend":[83],"on":[84],"its":[85,764],"depth,":[86],"duration,":[87],"context,":[89],"ability":[91,143],"to":[92,144,182,208,301,331,388,398,434,544,552,571,610,699],"engage":[93],"effective":[94],"This":[97,113,362,615],"conceptual":[98],"framework":[99,288],"provides":[100,363],"common":[102],"thread":[103,240],"linking":[104],"diverse":[106],"contributions":[107,649],"included":[108,495],"in":[109,122,255,359,496,650,756,762,777],"this":[110,180,242,438,497,651,778,785],"Research":[111,243,652,779],"Topic.":[112,244],"complexity":[114],"becomes":[115],"particularly":[116],"evident":[117],"when":[118,168,222],"considered":[121],"context":[124],"aging.":[126],"Marina":[127],"Gergues":[128],"al":[130,178,313,408,505,537,591],"emphasizes":[131],"reciprocal":[133],"relationship":[134],"between":[135,415,793],"natural":[138],"killer":[139],"(NK)":[140],"cells,":[141,257,634,638],"whose":[142],"eliminate":[145],"malignant":[146],"decline":[151],"with":[152,380,391,511,770],"age.":[153],"Immunosenescence":[154],"inflammaging":[156],"therefore":[158,284,441],"weaken":[159],"critical":[161,321],"mechanism":[162],"cell":[165],"surveillance":[166],"precisely":[167],"burden":[170],"increases.":[174],"Jia-Wen":[175],"Wang":[176],"extends":[179],"concept":[181,462],"oncolytic":[183],"virus":[184],"therapy,":[185],"highlighting":[186],"frailty":[189,221],"older":[191,229],"patients":[192],"as":[193,318,370,411,521,596,660,668],"potentially":[195,258,320],"important":[196,677,782],"determinant":[197,324],"both":[199],"efficacy":[200,711],"tolerability.":[202],"These":[203],"observations":[204,459],"underscore":[205],"need":[207],"move":[209],"beyond":[210,582],"chronological":[211],"age":[212],"incorporate":[214],"functional":[215,560,735],"measures":[216],"competence":[219],"designing":[223],"evaluating":[225],"immunotherapies":[227],"populations.The":[230],"therapeutic":[231,350,586,750],"implications":[232,578],"therapy-induced":[234],"(TIS)":[236],"represent":[237],"another":[238,597],"major":[239],"Chemotherapy,":[245],"radiotherapy,":[246],"targeted":[248],"agents":[249,381],"induce":[251],"phenotype":[254],"creating":[259],"an":[260,286,539,801],"immunogenic":[261],"state":[262,445,664],"subsequently":[265,280],"be":[266,302,686],"exploited":[267],"elimination.":[270,401],"\"one-two":[272],"punch\"":[273],"strategy":[274,386,804],"(i.e.,":[275],"first":[276],"inducing":[277,757],"eliminating":[281,759],"cells)":[283],"offers":[285],"attractive":[287],"integrating":[290],"into":[292,452],"precision":[293,806],"oncology.":[294],"induction":[297,346],"alone":[298],"unlikely":[300],"sufficient":[303],"[4].":[304],"work":[306],"discussed":[307],"Javier":[309],"A.":[310],"Menendez":[311],"highlights":[314],"mitochondrial":[315],"apoptotic":[316,383],"priming":[317],"underappreciated":[323],"response":[327],"TIS":[329,416],"CAR-T":[332],"CAR-NK":[334],"immunosenolytic":[335,477],"therapies.":[336],"Importantly,":[337],"persistence":[339],"pre-existing":[341],"anti-apoptotic":[342],"dependencies":[343],"after":[344],"suggests":[347],"vulnerability":[351],"be,":[356],"at":[357],"least":[358],"part,":[360],"predictable.":[361],"rationale":[365],"companion":[367],"diagnostics":[368],"such":[369,555],"BH3":[371],"profiling":[372],"rational":[375],"combinations":[376],"immunotherapy":[379,512],"targeting":[382,631],"dependencies.A":[384],"complementary":[385],"interfere":[389],"directly":[390],"mechanisms":[392],"allow":[394],"evade":[399],"review":[403],"Bei":[405],"Zhao":[406],"identifies":[409],"CD47":[410],"molecular":[413,484,566],"bridge":[414],"tolerance.":[419],"By":[420],"engaging":[421],"CD47-SIRP\u03b1":[423],"axis,":[424],"inhibit":[429],"phagocytic":[430],"clearance":[431],"contribute":[433,570,609],"persistence.":[436],"Targeting":[437],"pathway":[439],"could":[440,639],"transform":[442],"from":[446,657,688,725],"reservoir":[448],"therapy-resistant":[450],"therapeutically":[453],"exploitable":[454],"vulnerability.":[455],"More":[456],"broadly,":[457],"these":[458,729],"reinforce":[460],"surfaceome":[465],"provide":[470,781],"valuable":[472],"source":[473],"targets":[475],"approaches.The":[478],"potential":[479,523,550],"clinical":[480,746],"relevance":[481],"programs":[485],"illustrated":[488],"computational":[491],"multi-omics":[493,528],"studies":[494,775],"collection.":[498],"In":[499],"bladder":[500],"cancer,":[501],"Kaixuan":[502],"Du":[503],"developed":[506],"senescence-related":[508,565],"signature":[509],"associated":[510],"response,":[513],"prognosis,":[514],"landscape,":[518],"identifying":[519],"PPIL3":[520],"regulatory":[524],"target.":[525],"Similarly,":[526],"analysis":[529],"hepatocellular":[531],"carcinoma":[532],"Talaiti":[534],"Tuergan":[535],"identified":[538],"MCM7-associated":[540],"axis":[542],"linked":[543],"progression,":[546],"dysfunction,":[548],"resistance":[551],"immunotherapy.":[553],"Although":[554],"signatures":[556],"require":[557,732],"prospective":[558],"validation,":[561],"they":[562],"illustrate":[563],"how":[564],"features":[567],"eventually":[569],"patient":[572],"stratification":[573],"treatment":[575],"selection.Importantly,":[576],"extend":[581],"response.":[587],"Fabrizio":[588],"Antonangeli":[589],"introduce":[592],"\"innervated":[594],"niche\"":[595],"dimension":[598],"proposing":[604],"inflammation":[607],"neuroinflammation":[611],"cancer-associated":[613,645],"pain.":[614],"perspective":[616],"expands":[617],"biological":[619],"consequences":[620],"raises":[625],"intriguing":[627],"possibility":[628],"immune-mediated":[630],"including":[635],"through":[636],"NK":[637],"simultaneously":[640],"influence":[641],"control":[643],"symptoms.Collectively,":[646],"eight":[648],"Topic":[653,780],"support":[654],"shift":[656],"viewing":[658],"static":[662],"tumor-suppressive":[663],"toward":[665,784],"understanding":[666],"it":[667],"dynamic":[670],"component":[671],"ecosystem.":[675],"Several":[676],"questions":[678,730],"remain":[679],"open.":[680],"How":[681,703],"beneficial,":[683],"transient":[684],"distinguished":[687],"persistent,":[689],"tumor-promoting":[690],"senescence?":[691],"Which":[692],"senescent-cell":[693],"surface":[694],"markers":[695],"are":[696],"sufficiently":[697],"selective":[698],"permit":[700],"safe":[701],"immunosenolysis?":[702],"does":[704],"aging":[706],"system":[708],"alter":[709],"senescence-targeting":[713],"therapies?":[714],"And":[715],"biomarkers":[718],"reliably":[719],"predict":[720],"which":[721],"tumors":[722],"will":[723,731],"benefit":[724],"senogenicsenolytic":[726],"combinations?":[727],"Addressing":[728],"integration":[733],"assays,":[737],"single-cell":[738],"spatial":[740],"approaches,":[741],"profiling,":[743],"longitudinal":[745],"studies.":[747],"Ultimately,":[748],"opportunity":[751],"not":[753],"lie":[754],"simply":[755],"senescence,":[760],"but":[761],"controlling":[763],"timing,":[765],"location,":[767],"interaction":[769],"system.":[773],"gathered":[776],"steps":[783],"goal":[786],"suggest":[788],"manipulating":[790],"dialogue":[792],"effectors":[798],"become":[800],"increasingly":[802],"relevant":[803]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-01T00:00:00"}